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ABSTRACT OF THE THESIS

Bayesian Networks to Assess the Human Newborn Stool Metatranscriptome
by
William E. Bennett, Jr.
Master of Science in Computer Science
Washington University in St. Louis, 2016
Thesis Committee: Professor Michael R. Brent,
Professor Phillip I. Tarr,
Professor Roman Garnett
In human stool, a large population of bacterial genes and transcripts from hundreds of genera coexist with host
genes and transcripts. Assessments of the metagenome and transcriptome are particularly challenging, since there
is a great deal of sequence overlap among related species and related genes. We sequenced the total RNA content
from stool samples in a neonate using previously-described methods. We then performed stepwise alignment of
different populations of RNA sequence reads to different indices, including ribosomal databases, the human
genome, and all sequenced bacterial genomes. Each pool of RNA at each alignment step was subjected to
compression to assess sequence complexity in bits per symbol. In order to account for the high degree of overlap
among species, a Bayesian network tool (RNABayes) was constructed using a node based on 16S sequencing, and
a large number of nodes based on alignment scores to bacterial genes. The following algorithm was then
employed: (1) fit 16S census from a sample onto a Dirichlet distribution using maximum likelihood estimation to
get the conjugate prior, (2) estimate probabilities of each bacterial genus for each bacterial mRNA alignment using
BLAST alignment scores, (3) fit each of these probabilities to a Dirichlet distribution using maximum likelihood
estimation, (4) perform inference iteratively to update the conjugate prior, with the result being the posterior
probability distribution of metabolically active stool bacteria. This algorithm was then applied to three datasets:
(1) a simulated data set with normally distributed mRNAs, (2) a simulated data set with skewed mRNAs for a
single bacterial population, and (3) the RNASeq dataset from our newborn stool sample. Results indicate that a
Bayesian network built in this fashion reliably adjusts the prior bacterial population distribution to more accurately
reflect the transcriptionally active bacterial population. Application of this method to real world samples appears
to show even more marked skew, indicating transcripts are not uniformly distributed by population.
ix

Preface
The study of complex nucleic acid mixtures has made enormous strides in the past decade, but still
suffers from the Big Data Curse: more information does not necessarily yield greater understanding of
a complex process, and conversely, can often reveal further levels of complexity that only expand that
which we don’t know. I have found in most endeavors that believing something to be simple and
easily solved is highly fallacious, and in almost every case, once we know more about a problem, we all
too often discover that it’s way more complicated that we thought.
In the 1971 the United States government passed the National Cancer Act, which was billed politically
as a cure for cancer by the Nixon administration. The lay press, and many scientists and physicians,
predicted that with the right amount of investment of resources, we would soon see an end to cancer
in as little as a decade. Of course, this was strikingly optimistic, as we now see that cancer is an
extremely varied clinical endpoint to hundreds of distinct physiologic processes. Our understanding of
oncology remains incremental, but has benefited massively from genomic science.
Again in the late 1990’s, the Human Genome Project was billed as a panacea for a whole host of
human diseases. Once we knew the code for our genetic failures, we could cure a large number of
ailments, or predict them. While the Human Genome Project was certainly a massive scientific
achievement that has had ripples throughout science, the result has been, somewhat predictably, much
more complexity than was anticipated, and a deep realization that there are many more details of our
bodies that we do not understand. Knowing James Watson’s genetic makeup is only a tiny piece of the
puzzle. We must understand the diversity in our genomes and how they change over time, but even
then, the puzzle contains many more layers of complexity.
I believe they way forward from this expanding complexity problem is the use of rigorous probabilistic
methods. In this thesis I suggest a simple application of this idea by applying Bayesian networks to the
study of complex, multi-species RNA mixtures in human stools. But, I think Bayesian statistics could
be expanded to many more problems in medicine, and we would be all the better for it.

x

Chapter 1 - Background
The assessment of host and microbial transcripts in stool has received relatively little attention in the
past several decades. Initial assessments have been relatively simplistic, but with the genomics
revolution, massive datasets can be produced. Tools to illuminate useful biological information from
these data are lacking. What follows is a survey of the published data regarding stool mRNA
assessment.
Stool is a complex analyte containing a large number of bacterial and human cells, as well free protein
and undigested food debris. Inhibition of downstream reactions, such as PCR, is common. A variety
of methods have been used successfully to obtain pure RNA which is relatively free of inhibitors[1-3].

1.1

Viral Genomes

The first stool RNA species to be isolated in humans were those belonging to viral genomes. A large
number of enteric viruses, such as hepatitis A[4] virus, poliovirus[5], and rotavirus[6] have single- or
double-stranded RNA genomes, and the isolation of these viruses and their genomes have been
accomplished for decades. A number of investigators have isolated total RNA from stool for the
purposes of viral genotyping and discovery[7, 8], as a large percentage of enteric viruses have RNA
genomes. Furthermore, it is now possible to take a broader approach and assess the metagenome of
specific viruses or groups of viruses[9] both in infectious disease, but also in gastrointestinal disorders
such as inflammatory bowel disease, which have been shown to be related to dysbiosis of both the
microbiome and the virome[10].
While the techniques to isolate nucleic acid are similar, the information contained in genomic RNA is
distinct from that in the multitude of rRNAs and mRNAs within stool.

1.2

Colon Cancer Biomarkers

A large portion of the investigations of mRNA in stool has been related to the detection of specific
transcripts as putative biomarkers for colorectal adenocarcinoma in humans. Initial work was
1

performed by Davidson, et al when they followed up their previous study on protein kinase C (PKC)
expression in colon adenocarcinoma by assaying total stool mRNA from mouse stool for multiple
isoforms of PKC using RT-PCR[11]. They concluded this method would be useful to screen for colon
cancer, and their follow up studies in a rat tumor model showed stool PKC-b2 transcripts to be
elevated in animals with tumors[12].
Subsequent work has found that a variety of other markers might be useful in colon cancer. Davidson,
et al. applied their earlier methods to human samples, using RT-PCR to assay 11 different mRNAs in
controls, patients with inflammation, and patients with colorectal cancer[13], although no clear pattern
was seen among a small number of patients. Cyclo-oxygenase-2 (COX-2) is commonly overexpressed
in aerodigestive tumors, and COX-2 mRNA has been found in the stools of a small series of patients
with colorectal adenocarcinoma by Kanaoka, et al[14]. Subsequent work by the same group showed
that sensitivity improved with the addition of matrix metalloproteinase-7 mRNA measurement[15], and
that multiple other indicators (such as tumor size, number of exfoliated cells, and tumor expression of
COX-2) correlated positively with detectable stool COX-2 mRNA[16]. Another group showed a
somewhat lower sensitivity for detection of colon cancer using stool COX-2 mRNA[17]. Family
history of colorectal cancer and polyps has also been associated with an increase in stool COX-2
mRNA in healthy adult volunteers[18].
Yamao, et al. showed that CD44 variant transcripts, which had been previously found to be elevated in
tumor cells, were often present in adult humans with colorectal cancer, and post-operative samples
showed a decrease in these stool mRNAs[19]. Fecal cytokeratin 19 (CK19) and ribosomal protein L19
(RPL19) mRNAs have been shown to be associated with an increased risk of metastatic colorectal
cancer in a prospective cohort of adults[20]. In a recent study by Koga, et al., multiple stool mRNA
markers (CEA, MMP7, MYBL2, PTGS2 and TP53) were assayed in a large sample of patients with and
without colorectal cancer[21]. Their results were variable, with low sensitivity (58.3%), moderate
specificity (88.1%), and mRNA detection was dependent on the number of sloughed colonocytes
recovered in stool. Davidson’s group extended their previous work recently by simultaneously
measuring a large variety of stool mRNAs associated with insulin resistance and colorectal cancer, then
applied linear discriminate analysis to determine the most useful combinations of genes[22]. While
2

many researchers had expressed a need for analyses using multiple mRNA markers simultaneously, this
represents the first effort to do so mathematically.
Additionally, stool micro RNA (miRNA) screening shows promise in illuminating mechanisms of
physiology and disease when combined with other analyses, such as mRNA sequence[23]. miRNAs
are probably more stable in complex analytes like stool, and so may have an important future role in
noninvasive cancer screening[24].
Screening strategies using cancer-associated DNA sequences have now entered into the clinic and
received FDA-approval[25]. Recent work on targeted mRNA transcripts, such as integrins, seems to
show more promise as a useful clinical test than previous work.[26]

1.3

Bacterial Gene Expression

The assessment of bacterial virulence factors in vivo is of significant clinical interest, and has been the
target of several investigations. While measurement of transcripts in vitro from cultured bacteria from
human feces is a mainstay of microbiology, the direct assessment of mRNA in stool has not received as
much attention. In 2003, Fitzsimons et al. showed using quantitative RT-PCR that housekeeping genes
in Lactobacillus can be detected in stool when as little as 2x107 cells per gram of stool (about 0.1% of the
total bacterial population)[27]. While this work did not attempt to assess the native activity of stool
bacteria, it did show that bacterial mRNAs can be measured, and that they relate quantitatively to the
bacteria present. In vivo assessment of toxin gene expression by assaying stool mRNAs in Vibrio
cholerae infection could discern early from late phases of the disease[28], and in Escherichia coli O157:H7
showed differences between bovine and human infection[29]. More recently, Dunaev, et al. showed
that stool mRNA assessments to determine the quantity of viable non-culturable bacteria (VNCB) may
be a useful measure for quantifying potentially dangerous coliform bacteria, but that RNA isolation
from these biosolids is a challenging task[30].

3

1.4

Other Conditions

A variety of other human conditions have shown changes in stool mRNA content. A subset of adults
with HIV infection have been shown to have detectable HIV RNA and CD4 mRNA in their
stools[31]. Recently, Kaeffer et al. studied stool samples and gastric aspirates obtained from premature
infants, and found that several housekeeping mRNAs (b-actin, GAPDH, and PER1) are present in
measurable quantities in a majority of these samples[32]. Bennett et al. showed that there is
considerable inter-patient and inter-time variability in housekeeping (GAPDH) and inflammationassociated transcripts (IL-8, calprotectin) in stool, but that intra-specimen reproducibility is high[3].
The same group showed in a subsequent study that inflammatory transcripts were elevated in the
stools of children with bacterial colitis when compared with age-matched controls[33]. These same
approaches have been extended to other infections, such as C. difficile colitis, with similar results[34].
A similar disease process, environmental enteric dysfunction (EED), which is a complex interaction
between the gut microbiome, the host immune system, and the host nutritional status, has been
traditionally measured using more invasive and challenging techniques, such as lactulose permeability.
Newer approaches using transcriptomic sequencing have identified specific mRNAs associated with
EED, such as those associated with T-cell proliferation or mediators that dampen hormone response.
These have been shown to be comparable to more traditional techniques at detecting EED.

1.5

Transcriptomes of Environmental Samples

Chen et al. showed that individual bacterial transcripts can be measured in waste water (presumably
isolated from within biologically active cells), and that these correlate with nutrient availability and
bacterial contamination[35]. Since that time, several groups have taken an agnostic, sequence-based
approach to interrogation of total RNA in stool. Urich, et al. published results of the analysis of a
single 454 sequencing run on total RNA isolated from a soil sample[36]. Their results show that a
predominance of RNA reads are rRNA (74.8%), and that the remaining mRNAs are largely unaligned
or unassigned to a specific gene ontology (8.2% map to a specific gene, 17.0 % are unassigned).
Bacterial ribo-tags and mRNAs predominated in their samples. Bailly, et al. used a metatranscriptomic
4

approach to describe eukaryotic diversity, and compared 18S rRNA sequence with metagenomic DNA
sequencing [37]. Poor correlation was found between these two measures. Shrestha, et al. applied
3730 sequencing to total RNA enriched for mRNA using specific Shine-Dalgarno sequence primers
and found significant functional diversity in a paddy soil community [38].
Marine bacterial communities have also been a focus of metatranscriptomic analysis. In 2005,
Poretsky, et al. used selective hybridization to enrich freshwater lake samples for bacterial mRNAs, and
found a great deal of functional diversity along with many previously unknown sequences[39]. In
2008, Frias-Lopez, et al. performed 454 sequencing on a sample of marine surface water[40]. They
found ~ 85% of cDNA sequence (compared with ~ 50% of DNA sequence) did not align well to the
NCBI non-redundant protein database. Those sequences that did align were predominantly related to
photosynthesis and carbon fixation, consistent with the organisms’ ecological niche. Gilbert et al.
reported one of the first large-scale metatranscriptomic analyses of complex microbial communities by
applying 454 sequencing to a marine community and then analyzing both cDNA and DNA
sequence[41]. A surface water sample was subjected to an artificial “bloom,” and then samples were
obtained before, mid-bloom, and afterwards, so they could compare both DNA and cDNA among
different time points. They found a marked difference between the changes in DNA sequence when
compared to changes in cDNA sequence, and concluded this represents an alteration in gene
transcription within taxa, rather than a change in community structure. More recently, Hollibaugh, et
al. have demonstrated the strong potential of metatranscriptomic analysis to answer specific biological
questions by querying a series of 454 sequences for evidence of ammonia-oxidation performed by a
low-abundance organism (Crenarcheota)[42].
Fermentation samples have also been subjected to metatranscriptomic analysis, and have yielded
interestng insights. Nam, et al. were able to show that a number of lactic acid bacilli are present in
fermenting kimchi, and that, by metatranscriptomic analysis, these same bacteria are producing
transcripts consistent with participation in fermentation, and in ratios similar to their average relative
composition as determined by DNA sequencing[43]. Earlier this year, Weckx, et al. demonstrated a
similar scenario using microarray data in fermenting sourdough[44].
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1.6

Stool Transcriptomes

Stool is a convenient and readily available analyte for human studies, but until recently, the application
of metatranscriptomics to fecal samples has been sparse. Microarrays have been used to compare the
expression profiles of bifidobacteria in a small sample (4 patients) of breast-fed and formula-fed infants
aged 1 week to 10 months, and may be effective at differentiating the two groups biologically[45].
This work was expanded upon by Chapkin, et al., using microarrays to measure human expression
profiles in a larger number of breast-fed and formula-fed infants at 3 months of age[46]. Booijink, et
al. applied RNA-fingerprinting (using restriction fragment length polymorphisms) to the stools of two
healthy subjects, and found they could be accurately discriminated with this analysis[47]. Poroyko, et
al. used RNA-Seq to characterize the functional diversity of the stool microbiome in formula-fed vs.
mother-fed newborn piglets.
RNA sequencing has only more recently been applied to human stool samples. In the last year,
Turnbaugh, et al. reported the first detailed, deep, sequencing-based assessment of human stool
transcripts by comparing the expression profiles of two identical twins using RNA-Seq[48]. They
found considerable inter-individual differences, as well as a great number of transcripts encoding
hypothetical proteins. RNA-Seq continues to be used to assess specific disease states where invasive
biopsy or other assessment is difficult, such as to determine the intestinal maturation of preterm
infants[49].
Taken as a whole, the body of work studying stool RNA shows that a great deal of information is likely
to be present, but that extraction of this information is hindered by a combination of relative instability
of the analyte, as well as an unknown degree of uncertainty in alignment of reads and interpretation of
biological data.

1.7

The Problem - Why Use a Probabilistic Model?

A significant problem with mRNA alignments to a large number of bacterial genomes is the high
degree of homology among intestinal bacteria. Shigella and E. coli are virtually identical, for example.
6

Klebsiella and E. coli are also close evolutionary relatives with a high degree of gene homology. What’s
more, many unrelated bacteria may share plasmids or other functional genes acquired through gene
transfer after a long period of co-evolution in a shared environment. This often results in many high
scoring hits for each mRNA when cDNA sequence reads attempt to align to a large number of related
bacterial genomes.
Our proposed solution to this problem is the use of a Bayesian network to improve alignment fidelity
using two effects that are likely to change which mRNA-species pair is selected by an alignment: (1) the
alignment score, (2) the prevalence of a bacteria by 16S sequencing (which as we will see below is
probably more accurate than the alignments to rRNA in RNA-Seq). Such a model would be a large
web of interconnected probabilities ideally suited for a Bayesian network.

7

Chapter 2 – Materials and Methods
2.1

Samples

Stool samples were taken from a single male preterm infant born at 24 weeks estimated gestational age.
A single sample at 23 days of age, and another at 25 days of age were frozen at -80°C within 4 hours of
collection. Informed consent was obtained from the subject’s mother. Samples were collected as part
of an NIH-funded study to investigate the microbial contribution to necrotizing enterocolitis (NIH
UH2AI083266). The subject did not go on to develop necrotizing enterocolitis, so was considered a
control patient in the study with normal acquisition of gut microbiota.

2.2

Nucleic Acid Extraction

DNA was isolated using the QIAamp DNA Stool Mini Kit (QIAGEN, Benlo, Netherlands – Product
# 51504) in conjunction with the QIAcube automated nucleic acid isolation system (QIAGEN, Benlo,
Netherlands – Product # 9001292). Aqueous DNA was then subjected to 16S sequencing as described
below.
Total RNA was isolated from stools as described previously[3]. Briefly, frozen stool was subjected to a
sequence of bead-beating, phenol-chloroform extraction, and then silica column extraction. The final
silica column step was performed with the QIAcube, using the protocol provided by the manufacturer
for RNA isolation. RNA integrity was assessed using the Agilent 6000 Nano Kit (Agilent
Technologies, Santa Clara, CA, USA – Product # 5067-1511).

2.3

cDNA Production and Sequencing

DNA was subjected to 16S sequencing using protocols developed as part of the Human Microbiome
Project Demonstration Project on Necrotizing Enterocolitis. The first major publication from that
project[50] details the exact method employed:
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The V3-5 region of the 16S rRNA gene was sequenced on the Roche-454 platform to define
the composition of the bacterial community. Sample preparation, DNA isolation, sequencing,
data processing followed standardized protocols developed by the Human Microbiome Project
consortium. The minimal sequence length was 200 bp, and chimeric sequences were removed
by Chimera-Slayer. Average quality of scores of <35 were used as the minimum to remove lowquality reads. Sequences meeting the above criteria were further classified by the Ribosomal
Database Project (RDP) Naive Bayesian Classifier version 2.5 using training set 9 from phylum
to genus level[50].
The 16S profile of each sample was then recorded as a number of total reads aligning to the primer for
a specific V3-5 region of a specific bacterial genus. We then knew the proportion of each sample
constituting each bacterial genus.
cDNA for RNA-Seq was created using both the Nu-Gen Ovation and Nu-Gen Ovation Prokaryotic
enrichment systems. Sequencing was performed using the Illumina platform as described above.
Sequences obtained from the Ovation Prokaryotic / Illumina system were then used to study the effect
of Bayesian networks on the fidelity of assigning mRNA-organism pairs in complex mRNA mixtures.

2.4

Analysis

2.4.1

Overall Pipeline

The overall analysis pipeline is portrayed in Figure 1. Prior to alignment, reads were assessed for
quality using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). All reads were
first scrubbed of adapter and barcode sequences. Adapter sequences, bases with a Phred quality score
< 28, and reads with a length < 40 (for 100 bp reads) and < 20 (for 40 bp reads) after trimming were
removed using the FastX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Alignments were
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performed using Bowtie[51], with the addition of TopHat[52] for human alignments, to improve the
Figure 2.1 – Overall sequence analysis pipeline.

likelihood of correctly mapping reads that span
splice sites. Transcripts were assembled using
CuffLinks. Ribosomal indices were built using
the latest version of the SILVA database
containing all known ribosomal RNA
sequence[53]. Human indices were built using
the February 2009 (hg27) NCBI assembly.
Microbial indices were created using either all
microbial sequence deposited in NCBI, or by
creating custom indices based on the 16S
census of individual samples. All genera (or
families) with greater than a 0.1% contribution
to the microbial census by 16S sequence
analysis were included for each sample using all
sequence deposited in the NCBI for that genus
or family (both fully sequenced organisms and
draft sequence). rRNA, mRNA, and unaligned
bins were subjected to further analysis outlined
below.

Reads which aligned to rRNA sequence were compared, by genus (or family, if necessary), to those
genera and families which accounted for > 0.1% of the microbial census. In order to more accurately
make comparisons with 16S sequence data, rRNA sequences that aligned to hypervariable regions were
removed and compared separately. The percentage contribution to the microbial census was then
compared between 16S and rRNA-Seq.
Reads which aligned to ribosomal RNA or other non-coding RNAs (and were missed by the previous
ribosomal index alignment step) were removed prior to analysis of transcripts. For both microbial and
human alignments likely to be mRNAs transcripts were assembled and binned according to KEGG
10

category.
Additionally, a subset of specific human transcripts known to be involved in the maturation of the
human intestine, and in the control of gut inflammation, were assessed separately, and then compared
by relative abundance between samples and sequencing methods. These include: IL-1b, IL-6, IL-8,
IL-10, S100A8, TGF-b, TNF-a, TLR-2, TLR-4, HMGBP-1, EGF, and GAPDH.

2.4.2

Complexity Assessment

We assessed the average complexity of our sequence at each step of the alignment process to help
determine the likely contribution of each pool to unaligned reads. Complexity was determined by
compressing the total sequence of each pool of reads using the expert model (XM) compression
algorithm[54], and then computing the bits per symbol (BPS). This algorithm uses a series of experts:
a simple Markov expert, a context Markov expert that uses the previous 512 symbols, and a hash table
full of copy experts that encompass many combinations of potential sequence repeats. The relative
weight of each expert is computed by:

(2.1)
These weights are then combined using Bayesian averaging and their (relative) predictions used to
compress the given sequence:

(2.2)
Sequences with a higher average BPS thus has less sequence complexity since more information can be
stored per unit. For comparison, we used the same algorithm to compute the complexity of a
simulated set of repeated adapters (where we would expect low complexity), as well as simulated
11

random reads from human cDNA (where we would expect high complexity).

2.4.3

Creation of Simulated Reads

In order to test our Bayesian network, we needed to create simulated transcripts that varied in known
ways, so that we could then determine if the model accounted for these changes in a predictable way.
We simulated two sets of 1000 transcripts using built-in Python string functions:
1. A set of transcripts that were random at any coding portion of the genome and were normally
distributed around the frequency of each genera. The model should have minimal effect on the
posterior probability distribution of this data set.
2. A set of transcripts obtained identically as #1, but with a skewed frequency of genera.
Escherichia and Staphylococcus were the dominant genera, rather than Escherichia and Klebsiella.
These simulated sets of transcripts with known relationships with the 16S proportions could then
help determine the effectiveness of the model.

2.4.4

Fitting to and Sampling from the Dirichlet Distributions

Since our data consist of a distribution of the probability of several bacterial genera, we chose to use
the Dirichlet distribution. Additionally, the Dirichlet distribution is ideally suited for use as a conjugate
prior in a Bayesian network, which is described below.
All distributions were constructed and manipulated in our final software tool by modifying existing
modules written in Python. The NumPy (www.numpy.org) and SciPy (www.scipy.org) packages both
contain multiple classes helpful in the manipulation of Dirichlet distributions. Visualization of
distributions was accomplished using the matplotlib Python package (www.matplotlib.org).
The Dirichlet distribution is useful when we have a set of conjugate probabilities, as we do with 16S
data and data derived from mRNA alignment scores which are the conjugate probability of a set of
12

bacterial genera:

(2.3)
Where θ represents the probability of each bacterial genus being present in the 16S population or the
metabolically active mRNA population. These experimentally determined θ values can be used to
construct a Dirichlet distribution using maximum likelihood estimation (MLE), since the parameters
for the distribution (𝑎), are present in the following conditional probability:

(2.4)
MLE was performed on experimental θ values using an existing Python module written by Eric Suh
(https://github.com/ericsuh/dirichlet). The code was modified slightly to allow for longer
computation cycles, since many of the experimental data we attempted to fit had wide variability and
high Dirichlet parameters, which would often result in failure of the MLE algorithm to converge.
Additionally, since we usually had a single 16S or mRNA sample, we wanted to account for repeat
sample / intrasample variation, since our analyte (stool) is not homogenous. Some previous work has
shown intrasample variation of genus assignment to be low, about 5%[55]. So, when performing
parameter estimation, 100 samples were generated with a variation of 3-7% in the most common
genera, and subsequent genera adjusted randomly for that change, so that they all still summed to 1.
This also resulted in greater likelihood of the MLE algorithm converging, as performance was
noticeably poorer with smaller numbers of experimental samples for parameter estimation.
For the 16S census of the sample, the probabilities were straightforward, since the top 4 genera
accounted for the vast majority of the likelihood. As such, we built all subsequent distributions
using the probabilities of only these top 4 genera: Escherichia, Klebsiella, Staphylococcus,
and Enterobacter. We thus created the prior θ distribution of:
13

(2.5)
Assigning probabilities to mRNA alignments was more challenging. First, when aligning using BLAST,
only the top 4 genera were used as the index. Second, once an alignment score was generated for each,
probabilities were generated by determining the relative alignment score of each genus. If no
alignment occurred, the θ was set to 0 for that genus. If there were multiple genes that aligned to a
specific genus, the maximum alignment score was used.
We then had two data sets: (1) a 16S distribution that represented the prior probability of each genus,
(2) a set of several thousand alignments that represented many examples of the likelihood of each
mRNA being from one of those 4 genera. These θ’s could then be converted to Dirichlet distributions
and analyzed using a Bayesian network.

2.4.5

Bayesian Network Model for Prokaryotic mRNA

We constructed the Bayesian network according to the following schematic:
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Figure 2.2 – Bayesian network model schematic.

The single 16S node layer represents the prior probability (Dirichlet prior) of which genera are
metabolically active, which is simply those bacteria that we know to be present. As detailed in the
overall algorithm below, this prior probability is then updated by the many distributions in the second
layer via inference, resulting in a change in a successive change in the Dirichlet parameters, eventually
resulting in the posterior probability, which is the model’s estimate of the true metabolically active
population of bacteria.
We can therefore find a new distribution that is a re-parameterization of the initial Dirichlet prior:

(2.6)

2.4.6

The Algorithm – RNABayes

The RNABayes software tool was written using Python 2.7 with the following features:
Input: Set of 16S probabilities (1 or more), Set of mRNA probabilities (1 or more)
Output: Set of estimated proportions of metabolically active bacteria.
15

1.

Read in 16S probabilities in the format ([a, b, c, d]).

2.

Read in mRNA probabilities in the format ([a, b, c, d]).

3.

Use maximum likelihood estimation to generate parameters for a Dirichlet distribution for
each set of probabilities.

4.

Assign each of these Dirichlet distributions to nodes in a Bayesian network as described
above.

5.

Perform inference on each node, updating the prior probability in layer 1 with the
observations in layer 2.

6.

Return the final updated distribution from layer 1 as the estimate of the metabolically active
population of bacteria.
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Chapter 3 – Results and Conclusions
3.1 rRNA and 16S Census Comparison
We made multiple comparisons between 16S genus profiles and rRNA profiles obtained via RNASeq. We took all genera with >1% of the total and compared them across multiple variables: rRNA
vs. 16S, DOL 23 vs. DOL 25, between two runs of the same sample, and 16S V1-V3 vs. V3-V5.
These results are shown in Figures 3.1, 3.2, 3.3, and 3.4, respectively.
Figure 3.1

16S and RNA-Seq showed similar profiles, but RNA-Seq had far more variety, and probably reflects
the fact that RNA-Seq sequences a large number of less variable RNA regions which might align well
to multiple bacterial genomes, whereas V1-V3 provides greater resolution between genera.
Furthermore, some portions of rRNA may be less stable in environmental samples such as stool.
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Figure 3.2

The shift in bacterial species across a 48-hour period is consistent with comprehensive work
describing the transition of bacterial genera across the first few weeks of life[50]. Two genera
(Pseudomonas and Escherichia) show large reciprocal shifts, whereas the remaining portions are
unchanged.
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Figure 3.3

Figure 3.4
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There are only minor variations between multiple runs of RNA-Seq and between 16S rRNA gene
sequencing at different hypervariable regions, indicating that these are not important sources of
variation.

3.2 Human mRNA
Since human mRNA was only present from a single individual from a single species, we did not subject
it to further processing as we did with prokaryotic mRNA (see Bayesian Network Analysis for
Prokaryotic mRNA, above). Using MEGAN[56], we determined the KEGG category for all aligned
mRNA reads and compared DOL23 and DOL25. Results are shown in Figures 2.6 and 2.7 below.
The relative distribution was similar for each sample. We further determined the KEGG categories
for transcripts within the Metabolism category, since this was the dominant transcript type. The
majority of these alignments were for mRNAs coding for carbohydrate (CHO) metabolism. These
results are consistent with previous transcript profiles of individual gut microbiota, and with the overall
metabolic activity of gram negative and anaerobic gut bacteria[57, 58].
Figure 3.5 – KEGG categories for DOL 23
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Figure 3.6 – KEGG categories for DOL 25

3.3 Complexity Analysis
While we might assume that more complex sequence would consistently be present in mRNAs compared
to ribosomal sequence, this may not be true of all genes, and highly repetitive k-mers might make a larger
contribution to the mRNA sequence pool. However, in our sample, there was substantially more
complexity in non-rRNA (mean complexity = 1.24, median = 1.22) reads than in those aligning to rRNA
(mean complexity = 0.667, median = 0.635), as we might expect. Furthermore, the striking difference
between the average complexity at each alignment step when comparing DOL 23 and DOL 25 serves
to underscore the heterogeneity one expects to find in the large, heterogenous total RNA pool within
human stool.

21

Figure 3.7 – Read complexity with human and prokaryotic primers

3.4 Bayesian Network Model
3.4.1 Fitting Probabilities to the Dirichlet Distribution
With a 3-7% variation in the most common bacteria, the Dirichlet distribution had a high scalar for
parameters as determined by MLE. This resulted in a low variation in the probability density, as seen
in Figure 3.8 “16S”. When mRNA transcripts were simulated based on a normal distribution of the
most common bacteria, the distribution was slightly more dispersed, as seen in Figure 3.8 “Sim
Norm”. When a skew was added decreasing the likelihood of a Klebsiella transcript, the probability
distribution shifted to a new axis between Escherichia and Staphylococcus, but had a similar
dispersion, as seen in Figure 3.8 “Sim Skew.”
However, when actual RNA-Seq alignments were used, there was far more dispersion in probability
density, which has several potential causes:
1. High degree of homology between Klebsiella and Escherichia, resulting in frequently similar
alignment scores.
2. The frequent occurrence of a very low alignment score for 2 or more of the genera.
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3. The occurrence of a high degree of homology between all genera, likely in the case of heavily
conserved bacterial genes.
Figure 3.8 – Prior probability distributions for all datasets

3.4.2

Results from Inference on Simulated Data Set, Normally
Distributed

The simulated transcript set with a normally distributed change in transcripts behaved as expected.
There was a slightly more dispersion after the model adjustment than in the initial transcript set. The
shift towards Escherichia can likely be explained by a disproportionate change in the other parameters
(a 5% change in a higher probability was a 50% change in the lower probabilities).
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Figure 3.9 – Posterior probabilities for simulated data set, normal

3.4.3

Results from Inference on Simulated Data Set, Skewed

The skewed simulated transcript set also performed as expected. When the transcripts were skewed
to be predominantly Escherichia and Staphylococcus rather than Klebsiella, the probability density shifted to
the edge between the two dominant genera in the 16S data set (Escherichia and Klebsiella). The relative
dispersion remained similar, since transcripts were not otherwise selectively drawn from one genome
or another.
Figure 3.10 – Posterior probabilities for simulated data set, skewed

3.4.4

Results from Inference on RNA Seq Data Set

As the final analysis, we sought to determine how the model performed on a real data set. Both of the
24

simulated examples performed as we would expect, so we would also expect for the model to adjust
both the probabilities by genus, but also to likely increase the amount of uncertainty in the distribution,
since the two pieces of information (16S and RNA-Seq) contained such different predictions. Our
hypothesis was confirmed. The probability distribution expanded substantially, indicating a large
amount of uncertainty, and the region shifted towards Escherichia as we would expect.
Figure 3.11 – Posterior probability distribution for RNA Seq

3.5

Discussion

We have described a novel approach to improving the fidelity of alignment of complex bacterial mRNA
populations in human stool using Bayesian inference. The method relies on the construction of a small
Bayesian network using Dirichlet distributions to model the conjugate probabilities of the most
common bacterial constituents in a stool sample. Most work has focused on detection of the host
transcriptome, but we hope that further work building on probabilistic improvement of these complex
and difficult transcriptomes will help us gain further insight into the metabolic activity of these
important bacterial communities.
The results of the model are not surprising, and confirm the utility of Bayesian networks for this
application. In general, whichever direction the two sets of distributions (16S vs. RNA-Seq) tended to
differ, the model found a distribution with both (a) more uncertainty and (b) a shift towards the other
distribution. This may especially helpful in specific disease states where one or more populations of
bacteria are having a disproportionately large effect on the host.
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3.5.1

Weaknesses

There are several important weaknesses to this work. First, we had no gold standard to determine
efficacy of our Bayesian model in improving fidelity of aligning mRNA-species pairs correctly. While
the model performed modestly well on simulated reads, we are unable to determine if that performance
held for real world sequence, especially given how different the real samples were from the simulated
ones. There could be a cause of variation completely unrelated to the actual metabolic activity of the
bacteria in the sample (such as increased degradation of some mRNAs, different locations within the
stool of some bacteria vs. others). Secondly, only a small portion of total RNA was mRNA, which was
the eventual analyte we chose. Of those mRNAs, a minority were prokaryotic. Given the massive
community that is the human intestinal microbiome, it is surprising that we are able to see only a tiny
fraction of the bacterial transcriptome. However, we have no reason to believe there is disproportionate
degradation of one gene’s mRNA over another.

3.5.2

Future Directions

Future work in the use of probabilistic methods to assist in assessment of complex transcriptomes is
essential. Overall, the use of Bayesian methods to provide continually updated probabilities in complex
systems tends to improve outcomes at many levels. There are several research directions that would
continue to improve our understanding of complex transcriptomes:
1. Better systems biology at the level of bacterial communities, especially those occupying the human
host.
2. Better isolation methods and depth of sequencing. As sequencing technology continues to decrease
in cost, the coverage of single samples that can be achieved will only improve.
3. Expansion of Bayesian methods to analyze a large number of samples simultaneously.
Based on our preliminary results with this method, there are several improvements that could be made
to the software in later versions:

26

1. Parsing of reads or alignments without the need for preprocessing of data.
2. Ability to test the performance of different graph structures.
3. Additional analysis of Bayesian network performance.
4. Graphical interface.
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